Idarubicin alone or in combination with cytarabine and etoposide (3 + 3 + 5 protocol) in acute non-lymphoblastic leukaemia

Leuk Res. 1985;9(5):631. doi: 10.1016/0145-2126(85)90144-4.
No abstract available

Publication types

  • Letter

MeSH terms

  • Acute Disease
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Cytarabine / administration & dosage
  • Daunorubicin / administration & dosage
  • Daunorubicin / analogs & derivatives*
  • Daunorubicin / therapeutic use
  • Etoposide / administration & dosage
  • Female
  • Humans
  • Idarubicin
  • Leukemia / drug therapy*
  • Male
  • Middle Aged

Substances

  • Cytarabine
  • Etoposide
  • Idarubicin
  • Daunorubicin